A global study of 12 million people has found diabetes increases the risk of heart failure and this increase is greater for women than men. Researchers from The George Institute for Global Health determined that this differential was greater in Type 1 than Type 2 diabetes. Type 1 diabetes is associated with a 47% excess […]
了解更多[Sydney, Australia] 乔治临床( George Clinical ) congratulates its parent company, The George Institute for Global Health for securing $12 million from the National Health and Medical Research Coun […]
了解更多乔治临床( George Clinical ) congratulates its parent company, The George Institute for Global Health for securing a project grant that could transform the treatment of chronic kidney disease (CKD) […]
了解更多
Significant changes are ahead for clinical research in China. The Public Consultation Notice for Policies to Encourage Innovation and Reform in Regulation of Drug and Medical Device Clinical T […]
了解更多
Taiwan sits, along with its smaller counterparts, Singapore and Hong Kong, as one of the gateway countries to running a clinical trial in China. Although Hong Kong’s regulatory ties are more f […]
了解更多
Clinical trial sponsors and CROs don’t need to imagine South Korea as a country of limitless potential, they know it is. South Korea is a clinical trial destination with world-class medical in […]
了解更多
Increasingly, regulatory authorities are placing significant focus on clinical trial processes that ensure consistent, standardized, objective and unbiased reporting of safety and efficacy results; given that the definitions for many endpoint events include subjective components, and investigator-to-investigator subjective assessments may differ. Moreover, an increasing number of trials are now conducted in multiple geographies, and clinical […]
了解更多
In the world of healthcare, time is always of the essence. Researchers are continuously looking for new solutions to help improve patients’ well-being and ultimately save lives. The discovery process of new treatments takes an enormous amount of time and resources in order to generate good evidence to prove that they are safe and that […]
了解更多
A key step in developing a new drug is the transition from the laboratory to the human subject in a Phase I clinical trial, where the new compound is given to humans for the first time. A Phase I trial is the gateway between scientific research and clinical medicine. Generally, in-human Phase I studies are […]
了解更多
Thrombolysis will continue to be the mainstay for acute stroke treatment, despite the recent revolution in neurointerventional clot retrieval. However, as there are ongoing limitations of thrombolysis of bleeding risk and reduced efficacy in large clots – what possible therapeutic advancements can complement or act as an adjuvant to thrombolysis? Neurointervention – effective, but limited […]
了解更多
